$FIXX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Homology Medicines, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Homology Medicines, Inc.. Get notifications about new insider transactions in Homology Medicines, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 27 2018 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 20.04 | 1,187 | 23,783 | 246,658 | 247.8 K to 246.7 K (-0.48 %) |
| Nov 27 2018 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 20.04 | 28,495 | 570,926 | 5,919,836 | 5.9 M to 5.9 M (-0.48 %) |
| Nov 27 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 20.04 | 1,187 | 23,783 | 246,658 | 247.8 K to 246.7 K (-0.48 %) |
| Nov 27 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 20.04 | 28,495 | 570,926 | 5,919,836 | 5.9 M to 5.9 M (-0.48 %) |
| Nov 20 2018 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 20.20 | 21,036 | 424,927 | 247,845 | 268.9 K to 247.8 K (-7.82 %) |
| Nov 20 2018 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 20.20 | 504,864 | 10,198,253 | 5,948,331 | 6.5 M to 5.9 M (-7.82 %) |
| Nov 20 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 20.20 | 21,036 | 424,927 | 247,845 | 268.9 K to 247.8 K (-7.82 %) |
| Nov 20 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 20.20 | 504,864 | 10,198,253 | 5,948,331 | 6.5 M to 5.9 M (-7.82 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,187,535 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,204,502 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Buy | C | 0.00 | 5,392,037 | 0 | 6,722,076 | 1.3 M to 6.7 M (+405.40 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Option Exercise | C | 0.00 | 6,944,444 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Option Exercise | C | 0.00 | 6,944,445 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Option Exercise | C | 0.00 | 3,521,126 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Option Exercise | C | 0.00 | 3,521,126 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Buy | P | 16.00 | 625,000 | 10,000,000 | 625,000 | 0 to 625 K |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Buy | P | 16.00 | 625,000 | 10,000,000 | 2,613,517 | 2 M to 2.6 M (+31.43 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Buy | C | 0.00 | 1,319,483 | 0 | 1,988,517 | 669 K to 2 M (+197.22 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Buy | C | 0.00 | 1,319,484 | 0 | 1,988,518 | 669 K to 2 M (+197.22 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Buy | C | 0.00 | 669,034 | 0 | 669,034 | 0 to 669 K |
| Apr 04 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Buy | C | 0.00 | 669,034 | 0 | 669,034 | 0 to 669 K |
| Apr 04 2018 | FIXX | Homology Medicines ... | SHAH MAHENDRA | Director | Option Exercise | C | 0.00 | 659,742 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | SHAH MAHENDRA | Director | Grant | A | 16.00 | 500,000 | 8,000,000 | 1,159,742 | 659.7 K to 1.2 M (+75.79 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | SHAH MAHENDRA | Director | Buy | C | 0.00 | 659,742 | 0 | 659,742 | 0 to 659.7 K |
| Apr 04 2018 | FIXX | Homology Medicines ... | GILLIS STEVEN | Director | Option Exercise | C | 0.00 | 1,385,457 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | GILLIS STEVEN | Director | Option Exercise | C | 0.00 | 4,683,238 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | GILLIS STEVEN | Director | Buy | C | 0.00 | 6,068,695 | 0 | 6,068,695 | 0 to 6.1 M |
| Apr 04 2018 | FIXX | Homology Medicines ... | ARCH Venture Fund VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,385,457 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | ARCH Venture Fund VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 4,683,238 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | ARCH Venture Fund VIII, L.P. | 10% Owner | Buy | C | 0.00 | 6,068,695 | 0 | 6,068,695 | 0 to 6.1 M |
| Apr 04 2018 | FIXX | Homology Medicines ... | Rock Springs Capital Managemen ... | 10% Owner | Option Exercise | C | 0.00 | 395,845 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | P | 16.00 | 250,000 | 4,000,000 | 645,845 | 395.8 K to 645.8 K (+63.16 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | Rock Springs Capital Managemen ... | 10% Owner | Buy | C | 0.00 | 395,845 | 0 | 395,845 | 0 to 395.8 K |
| Apr 04 2018 | FIXX | Homology Medicines ... | Vida Ventures, LLC | 10% Owner | Option Exercise | C | 0.00 | 395,845 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | Vida Ventures, LLC | 10% Owner | Buy | P | 16.00 | 375,000 | 6,000,000 | 770,845 | 395.8 K to 770.8 K (+94.73 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | Vida Ventures, LLC | 10% Owner | Buy | C | 0.00 | 395,845 | 0 | 395,845 | 0 to 395.8 K |
| Apr 04 2018 | FIXX | Homology Medicines ... | Temasek Holdings (Private) Ltd | 10% Owner | Option Exercise | C | 0.00 | 989,612 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | Temasek Holdings (Private) Ltd | 10% Owner | Option Exercise | C | 0.00 | 1,605,681 | 0 | 0 | |
| Apr 04 2018 | FIXX | Homology Medicines ... | Temasek Holdings (Private) Ltd | 10% Owner | Buy | P | 16.00 | 625,000 | 10,000,000 | 3,220,293 | 2.6 M to 3.2 M (+24.08 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | Temasek Holdings (Private) Ltd | 10% Owner | Buy | C | 0.00 | 989,612 | 0 | 2,595,293 | 1.6 M to 2.6 M (+61.63 %) |
| Apr 04 2018 | FIXX | Homology Medicines ... | Temasek Holdings (Private) Ltd | 10% Owner | Buy | C | 0.00 | 1,605,681 | 0 | 1,605,681 | 0 to 1.6 M |
| Mar 29 2018 | FIXX | Homology Medicines ... | Thistle Mary | Director | Option Exercise | A | 16.00 | 31,160 | 498,560 | 31,160 | |
| Mar 29 2018 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Option Exercise | A | 16.00 | 92,376 | 1,478,016 | 92,376 | |
| Mar 29 2018 | FIXX | Homology Medicines ... | Wheeler Cameron | Director | Option Exercise | A | 16.00 | 31,160 | 498,560 | 31,160 | |
| Mar 29 2018 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Option Exercise | A | 16.00 | 66,501 | 1,064,016 | 66,501 | |
| Mar 29 2018 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Option Exercise | A | 16.00 | 31,160 | 498,560 | 31,160 | |
| Mar 29 2018 | FIXX | Homology Medicines ... | Gregory Richard J. | Director | Option Exercise | A | 16.00 | 31,160 | 498,560 | 31,160 | |
| Mar 29 2018 | FIXX | Homology Medicines ... | Patterson Matthew R | Director | Option Exercise | A | 16.00 | 8,360 | 133,760 | 8,360 | |
| Mar 29 2018 | FIXX | Homology Medicines ... | Rasty Siyamak | Chief Operating Off ... | Option Exercise | A | 16.00 | 30,780 | 492,480 | 30,780 | |
| Mar 29 2018 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Option Exercise | A | 16.00 | 49,711 | 795,376 | 49,711 | |
| Mar 29 2018 | FIXX | Homology Medicines ... | GILLIS STEVEN | Director | Option Exercise | A | 16.00 | 31,160 | 498,560 | 31,160 | |
| Mar 29 2018 | FIXX | Homology Medicines ... | SHAH MAHENDRA | Director | Option Exercise | A | 16.00 | 31,160 | 498,560 | 31,160 | |
| Mar 29 2018 | FIXX | Homology Medicines ... | Flynn James E | Director | Option Exercise | A | 16.00 | 31,160 | 498,560 | 31,160 |